Sökning: "hepatobiliary tract"

Hittade 3 avhandlingar innehållade orden hepatobiliary tract.

  1. 1. Enteric Helicobacter and H. pylori in chronic inflammation and cancer of the hepatobiliary tract and pancreas

    Författare :Hans-Olof Nilsson; Avdelningen för medicinsk mikrobiologi; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Mikrobiologi; mykologi; virology; bacteriology; Microbiology; hepatocellular cancer; Helicobacter; PCR-denaturing gradient gel electrophoresis; oncology; cancerology; Cytologi; onkologi; cancer; mycology; bakteriologi; virologi; Cytology;

    Sammanfattning : The Helicobacter genus now consists of at least 26 species, with additional novel species in the process of being validated. Beyond the impact of H. LÄS MER

  3. 2. Ulcerative colitis and cancer with special reference to the increased colorectal cancer risk

    Författare :Per Karlén; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Ulcerative colitis; cancer; inflammatory bowel disease; colorectal cancer; colonoscopic surveillance; epidemiology; flow cytometry DNA; Sialyl-Tn antigen; primary sclerosing cholangitis; hepatobiliary tract; case-control studies;

    Sammanfattning : The association between ulcerative colitis (UC) and cancer in a defined geographical region in Sweden was analyzed. UC patients have an increased overall risk of cancer of 40%, mainly due not only to the well-known increased risk of colorectal cancer (CRC) but also to the risk of hepatobiliary cancer associated with primary sclerosing cholangitis (PSC). LÄS MER

  4. 3. Immunological aspects on prognosis in resectable cholangiocellular cancer

    Författare :Hannes Jansson; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Background: Biliary tract cholangiocellular cancers, cholangiocarcinoma (CCA) and gallbladder cancer (GBC), are malignancies with poor prognosis. Even after resection surgery with curative intent, a majority of patients suffer recurrence, and median overall survival (OS) remains limited to approximately three years. LÄS MER